Tecan Group Ltd (TECN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Tecan Group Ltd (TECN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7193
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation suppliers. Its product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan’s products find applications in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions and synthetic biology. The company has manufacturing facilities, and research and development facilities in Europe and North America. Tecan is headquartered in Mannedorf, Zurich, Switzerland.

Tecan Group Ltd (TECN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Tecan Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Tecan Group Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 10
IBL International And Leiden University Medical Centre Enter Into Licensing Agreement For Myasthenia Gravis Diagnostics 11
Radisens Enters Into Licensing Agreement With Tecan 12
DiaSorin Enters into Agreement with Tecan 13
Singulex Enters Into Co-Development Agreement With Tecan 14
ViroGates Enters Into Distribution Agreement With IBL International 15
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 16
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 17
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 18
Reinnervate Enters Into Co-Development Agreement With Tecan Group 19
University of Duisburg-Essen Enters Into Licensing Agreement With IBL International 20
Acquisition 21
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 21
Tecan Acquires SPEware 22
Tecan Completes Acquisition of IBL International for USD39 Million 23
Tecan Group Ltd – Key Competitors 24
Tecan Group Ltd – Key Employees 25
Tecan Group Ltd – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Aug 16, 2018: H1 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business 28
Aug 16, 2018: Tecan: Financial results for the first half of 2018 31
Aug 16, 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business 34
Aug 16, 2017: H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business 37
Mar 15, 2017: Full year 2016: Another year of double-digit sales growth for Tecan 40
Corporate Communications 43
Oct 06, 2017: Tecan initiates succession process for the Board of Directors 43
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development 44
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development 45
Jan 10, 2017: Tecan appoints Klaus Lun Head of the Life Sciences Business division 46
Other Significant Developments 47
Jul 03, 2018: Tecan’s Spark reader aiding research into rare skin disease 47
Jan 25, 2018: Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Tecan Group Ltd, Medical Equipment, Key Facts, 2017 2
Tecan Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Deals By Market, 2012 to YTD 2018 8
Tecan Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 10
IBL International And Leiden University Medical Centre Enter Into Licensing Agreement For Myasthenia Gravis Diagnostics 11
Radisens Enters Into Licensing Agreement With Tecan 12
DiaSorin Enters into Agreement with Tecan 13
Singulex Enters Into Co-Development Agreement With Tecan 14
ViroGates Enters Into Distribution Agreement With IBL International 15
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 16
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 17
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 18
Reinnervate Enters Into Co-Development Agreement With Tecan Group 19
University of Duisburg-Essen Enters Into Licensing Agreement With IBL International 20
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 21
Tecan Acquires SPEware 22
Tecan Completes Acquisition of IBL International for USD39 Million 23
Tecan Group Ltd, Key Competitors 24
Tecan Group Ltd, Key Employees 25
Tecan Group Ltd, Subsidiaries 26

List of Figures
Tecan Group Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Tecan Group Ltd (TECN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teijin Ltd (3401)-製薬・医療分野:企業M&A・提携分析
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • Oriental Land Co., Ltd.:企業の戦略・SWOT・財務分析
    Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nippon Suisan Kaisha, Ltd.
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The New Zealand Refining Co Ltd (NZR):企業の財務・戦略的SWOT分析
    The New Zealand Refining Co Ltd (NZR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Scienion AG:製品パイプライン分析
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …
  • Ultragenyx Pharmaceutical Inc.:企業の戦略・SWOT・財務分析
    Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Dyadic International Inc (DYAI):企業の財務・戦略的SWOT分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that develops, discovers, manufactures, and commercializes protein-based drugs. The company utilizes its patented and proprietary technology Myceliopthora thermophila expression systems to conduct research and produce industrial en …
  • Bio Osmo Berhad:企業の戦略・SWOT・財務情報
    Bio Osmo Berhad - Strategy, SWOT and Corporate Finance Report Summary Bio Osmo Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Fukoku Mutual Life Insurance Company:企業の戦略・SWOT・財務情報
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Cypress Energy Partners LP (CELP):企業の財務・戦略的SWOT分析
    Summary Cypress Energy Partners LP (Cypress Energy), a subsidiary of Cypress Energy Holdings LLC, is an energy services company that provides midstream services. The company provides services such as pipeline inspection, integrity and hydrostatic testing services to energy, exploration and productio …
  • New Silkroad Culturaltainment Limited.:企業の戦略・SWOT・財務分析
    New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report Summary New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • RayBiotech Inc-製薬・医療分野:企業M&A・提携分析
    Summary RayBiotech Inc (RayBiotech) is a life science company that offers proteins, antibodies and immunological kits. The company’s products include antibody arrays, elisa, functional assays, antibodies and custom recombinant protein service. It provides services such as testing services, custom se …
  • Strata Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Strata Oncology Inc (Strata Oncology) is a precision oncology company. The company offers tumor sequencing to advanced cancer patients and a portfolio of biomarker-matched precision medicine trials. It identifies patients to design and conduct transformative precision oncology trials to acce …
  • Marafiq:企業の戦略的SWOT分析
    Marafiq - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Apyx Medical Corp (BVX):企業の財務・戦略的SWOT分析
    Summary Apyx Medical Corp (Apyx Medical) formerly known as Bovie Medical Corp is a medical technology company. The company manufactures and develops cosmetic and surgical products. The company also develops J-Plasma, a helium-based plasma surgical product for cutting, coagulation and ablation of sof …
  • Singapore Technologies Engineering Ltd (S63):企業の財務・戦略的SWOT分析
    Singapore Technologies Engineering Ltd (S63) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Otis Elevator Co:企業の戦略・SWOT・財務情報
    Otis Elevator Co - Strategy, SWOT and Corporate Finance Report Summary Otis Elevator Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cell C (Pty) Ltd.:企業の戦略・SWOT・財務情報
    Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Boeing Company:企業の戦略・SWOT・財務情報
    The Boeing Company - Strategy, SWOT and Corporate Finance Report Summary The Boeing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Macquarie Bank Ltd:企業のM&A・事業提携・投資動向
    Macquarie Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Macquarie Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆